1. Home
  2. PHAR vs CSV Comparison

PHAR vs CSV Comparison

Compare PHAR & CSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • CSV
  • Stock Information
  • Founded
  • PHAR 1988
  • CSV 1991
  • Country
  • PHAR Netherlands
  • CSV United States
  • Employees
  • PHAR N/A
  • CSV N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • CSV Other Consumer Services
  • Sector
  • PHAR Health Care
  • CSV Consumer Discretionary
  • Exchange
  • PHAR Nasdaq
  • CSV Nasdaq
  • Market Cap
  • PHAR 731.1M
  • CSV 693.8M
  • IPO Year
  • PHAR N/A
  • CSV 1996
  • Fundamental
  • Price
  • PHAR $10.31
  • CSV $46.59
  • Analyst Decision
  • PHAR Strong Buy
  • CSV Strong Buy
  • Analyst Count
  • PHAR 3
  • CSV 2
  • Target Price
  • PHAR $30.00
  • CSV $50.50
  • AVG Volume (30 Days)
  • PHAR 3.6K
  • CSV 84.3K
  • Earning Date
  • PHAR 07-31-2025
  • CSV 07-30-2025
  • Dividend Yield
  • PHAR N/A
  • CSV 0.97%
  • EPS Growth
  • PHAR N/A
  • CSV 47.76
  • EPS
  • PHAR N/A
  • CSV 2.99
  • Revenue
  • PHAR $320,708,000.00
  • CSV $407,774,000.00
  • Revenue This Year
  • PHAR $13.31
  • CSV $1.96
  • Revenue Next Year
  • PHAR $7.68
  • CSV $2.93
  • P/E Ratio
  • PHAR N/A
  • CSV $15.54
  • Revenue Growth
  • PHAR 24.13
  • CSV 4.42
  • 52 Week Low
  • PHAR $6.65
  • CSV $26.73
  • 52 Week High
  • PHAR $12.61
  • CSV $47.48
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 43.60
  • CSV 61.17
  • Support Level
  • PHAR $9.99
  • CSV $45.75
  • Resistance Level
  • PHAR $10.49
  • CSV $47.21
  • Average True Range (ATR)
  • PHAR 0.34
  • CSV 0.93
  • MACD
  • PHAR -0.14
  • CSV 0.03
  • Stochastic Oscillator
  • PHAR 7.45
  • CSV 72.62

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

Share on Social Networks: